Clinical Trial: INFLUENCE of ORIGINAL NATIVE TRICUSPID VALVE LESION (STENOSIS or STENO-INSUFFICIENCY or INSUFFICIENCY) on POST-IMPLANT STRUCTURAL BIOPROSTHETIC DEGENERATION AFTER TRICUSPID VALVE REPLACEMENT.

U.S., March 14 -- ClinicalTrials.gov registry received information related to the study (NCT06875154) titled 'INFLUENCE of ORIGINAL NATIVE TRICUSPID VALVE LESION (STENOSIS or STENO-INSUFFICIENCY or INSUFFICIENCY) on POST-IMPLANT STRUCTURAL BIOPROSTHETIC DEGENERATION AFTER TRICUSPID VALVE REPLACEMENT.' on March 07.

Brief Summary: The structural deterioration process of the implanted bioprosthesis in tricuspid position for tricuspid valve pathology is gradual and irreversible and includes many changes, such as pannus growth, leaflet fibrosis and calcification, delamination of the connective tissue, ruptures and perforations of leaflets. 8 In the great majority of cases SVD consists of leaflet calcium deposits and can be clinically associated...